| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/02/2006 | EP1056878B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 08/02/2006 | EP0696206B1 Adenoviruses having modified fiber proteins |
| 08/02/2006 | CN1813061A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/02/2006 | CN1813000A Synthetic antibody phage libraries |
| 08/02/2006 | CN1810961A Recombinant influenza virus and its prepn and application |
| 08/01/2006 | US7084266 Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof |
| 08/01/2006 | US7083981 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/01/2006 | US7083795 Inactivated respiratory syncytial viral vaccines |
| 08/01/2006 | CA2250714C Animal cells and processes for the replication of influenza viruses |
| 07/27/2006 | WO2006078975A2 Improved vaccine against feline calicivirus |
| 07/27/2006 | WO2006077020A2 Method for the specific or unspecific separation of cells and/or viruses from aqueous media and use thereof |
| 07/27/2006 | WO2006034319A3 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 07/27/2006 | WO2004106360A3 Viral vectors with improved properties |
| 07/27/2006 | US20060166364 Use of flexible bag containers for viral production |
| 07/27/2006 | US20060166363 Modified baculovirus expression system for production of pseudotyped rAAV vector |
| 07/27/2006 | US20060166345 Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses |
| 07/27/2006 | US20060166321 Recombinant influenza vectors with tandem transcription units |
| 07/27/2006 | US20060166318 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 07/27/2006 | US20060166225 Methods and compositions for polypeptide engineering |
| 07/27/2006 | US20060166187 Hbv precore protein capable of forming particles |
| 07/27/2006 | US20060165727 Vaccine; inducing an immune response; infectious diseases, which can be caused by more than one strain, clade, variant, subtype or serotype of infectious disease causing microorganism; reliable vaccination against all Dengue virus serotypes |
| 07/27/2006 | US20060165725 HBV drug resistance drug resistance detection methods |
| 07/27/2006 | US20060165724 Method of producing infectious reovirus |
| 07/27/2006 | CA2595534A1 Improved vaccine against feline calicivirus |
| 07/27/2006 | CA2567446A1 Alphavirus vectors for respiratory pathogen vaccines |
| 07/27/2006 | CA2563538A1 Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 07/26/2006 | EP1683858A2 Viral preparations, vectors, immunogens, and vaccines |
| 07/26/2006 | EP1682568A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 07/26/2006 | EP1351974B1 Using viruses to detect or purify proteins |
| 07/26/2006 | EP0967991B1 Infectious bursitis vaccine |
| 07/26/2006 | CN1809633A Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 07/26/2006 | CN1807609A Thermostable lactase preparation method |
| 07/26/2006 | CN1807602A Preparation method of recombinant baculoviral for constructing fowl vaccine |
| 07/26/2006 | CN1807599A Method for safe continuous enclosed cell culture, virus production/ inactivation |
| 07/25/2006 | US7081518 For the diagnosis and therapy of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081342 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 07/20/2006 | WO2006076408A1 Cancer-targeted viral vectors |
| 07/20/2006 | WO2006076343A1 Mycobacteria expressing hiv-1 and malaria antigens |
| 07/20/2006 | WO2006074524A1 Virus recovery medium, use thereof and viral diagnostic kit including same |
| 07/20/2006 | WO2006051069A3 Defective influenza virus particles |
| 07/20/2006 | WO2005117983A3 Carrier conjugates of tnf-peptides |
| 07/20/2006 | US20060160202 Bacterial artificial chromosome vector for use in the propagation and transfer of genetic material; equine herpesvirus (EHV) |
| 07/20/2006 | US20060160130 Recombinant RSV virus expression systems and vaccines |
| 07/20/2006 | US20060160067 GBV-B polynucleotide coding a virus having domain III of the 5' neurotrophin region from a hepatitis C virus 5' NTR, and at least part of a structural or non-structural protein coding region of HCV; viral expression construct; infectious GBV-B molecular clone |
| 07/20/2006 | US20060159706 Novel insertion sites in pox vectors |
| 07/20/2006 | US20060159704 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents |
| 07/20/2006 | US20060159703 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 07/20/2006 | US20060159700 Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation |
| 07/20/2006 | US20060159699 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2006 | US20060159659 RNA picornavirus; selectively kills some types of tumors; making new oncolytic virus derivatives and of altering viruses to have tumor-specific tropisms |
| 07/20/2006 | CA2594412A1 Virus recovery medium, use thereof and viral diagnostic kit including same |
| 07/20/2006 | CA2593684A1 Cancer-targeted viral vectors |
| 07/20/2006 | CA2587321A1 Improved prrs vaccines |
| 07/20/2006 | CA2567047A1 Alphavirus replicon packaging constructs |
| 07/20/2006 | CA2562457A1 Reporter plasmid phage packaging system for detection of bacteria |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1282712B1 Synthetic gagpol genes and their uses |
| 07/19/2006 | EP1255815B1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 07/19/2006 | EP1015561B1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| 07/19/2006 | CN1804031A Method for reforming high-virulent nuclear polyhedrosis virus of lepidoptera pest |
| 07/19/2006 | CN1804030A Technique for constructing high-virulent nuclear polyhedrosis virus of lepidoptera pest |
| 07/19/2006 | CN1804029A Method for constructing non-virulent strain of infectious bursal disease virus |
| 07/19/2006 | CN1803838A Follicle stimulating hormone receptor(FSHR) specific binding region polypeptide, its expression vector, preparation method and application in drug preparation |
| 07/19/2006 | CN1264975C Recopulated strain of rotavirus gene |
| 07/19/2006 | CN1264860C Method for surface display of proteins on genetic carriers |
| 07/18/2006 | US7078586 Papaya ringspot virus genes |
| 07/18/2006 | US7078383 Genetic engineered protein; enzyme inhibitor; respiratory system disorders; genetic disorders |
| 07/18/2006 | US7078218 replicon RNAs are electroporated into permissive cells and are harvested from the surfaces of the cells using a salt wash in which the salt concentration is from about 0.2 to about 5 M sodium/calcium/magnesium/potassium chloride |
| 07/18/2006 | US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 07/18/2006 | US7078031 delivering genes; gag genes, gag protein; endothelial growth factor |
| 07/18/2006 | US7078029 Having a genome with a mutation of a TAATGARAT sequence such that, in the presence of a ICP4 gene product, a native immediate early gene is expressed from the genome with delayed kinetics |
| 07/18/2006 | US7078028 Anti-neoplastic viral agents |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/13/2006 | WO2006060314A3 Generation of replication competent viruses for therapeutic use |
| 07/13/2006 | US20060154892 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 07/13/2006 | US20060153874 Recombinant poxvirus comprising at least two compox ati promoters |
| 07/13/2006 | US20060153873 Smallpox vaccine |
| 07/13/2006 | US20060153872 Methods of producing influenza vaccine compositions |
| 07/13/2006 | US20060153871 vaccine comprising the virus; immunization; diagnostic method comprising contacting a physiological sample of an animal suspected of containing antiinfluenza virus antibodies with the claimed virus |
| 07/13/2006 | US20060153870 Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153810 Process for preparing retrovirus vector for gene therapy |
| 07/12/2006 | EP1679376A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/12/2006 | EP1679368A1 Methods for purifying viruses |
| 07/12/2006 | EP1678292A2 Improved mva vaccines |
| 07/12/2006 | EP1678193A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 07/12/2006 | EP1349926B1 Complementing cell lines |
| 07/12/2006 | CN1802173A Packaged virus-like particles |
| 07/12/2006 | CN1800376A Recombinant T4 phage for displaying influenza virus non-structural protein NS1 and its uses |
| 07/12/2006 | CN1800375A Recombinant adenovirus of porcine reproductive and respirator syndrome virus and porcine Circovirus, and vaccine |
| 07/12/2006 | CN1800374A Recombinant gene engineered strain of aujeszkys disease-porcine reproductive and respirator syndrome virus and its uses |
| 07/12/2006 | CN1800229A Preparation of monodispersion high molecular nanometer sphere using envelop virus as template |
| 07/12/2006 | CN1263864C Recombinant adenoviral vector and methods of use |
| 07/12/2006 | CN1263853C Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 07/12/2006 | CN1263848C Artificially recombinant H9N2 hypotype influenza virus and its uses |
| 07/11/2006 | US7074557 Isolating preferentially binding particles; obtain nucleotide sequences, incubate with translation appataratus, expose to preferential particles, recover encapsulated complex |
| 07/11/2006 | US7074553 Retrovirus associated with myelodysplastic syndromes and uses thereof |
| 07/11/2006 | US7074414 Cold-adapted equine influenza viruses |
| 07/11/2006 | US7074413 Using reverse genetics to combine the antigenic determinants that render the rabies virus non-pathogenic with the determinants that are responsible for the elicitation of an effective anti-rabies immune response |